Results 231 to 240 of about 104,274 (313)

Experiences of Drainage and Associated Impacts: A Qualitative Study Among Patients With Hidradenitis Suppurativa

JEADV Clinical Practice, EarlyView.
This study provides an in‐depth account of patients' experiences of drainage as a symptom of hidradenitis suppurativa. The HIDE Scale© facilitates incorporation of these insights into clinical practice, supporting person‐centred approaches that enhance clinical assessment, reduce stigma, and strengthen patient–clinician communication.
Stine Thestrup Hansen, Bente Villumsen, Mina Shereen Khaled, Terri Shih, Steven Daveluy, Amit Garg, Susanne de Goeij, Barry M. McGrath, Peter Theut Riis, Kari Zalik, Jennifer L. Hsiao, Camilla G. Frederiksen, Noor F. Goandal, Hans Christian Ring, Joseph Dowsett, Rahul Masson, John R. Ingram, Gregor B. E. Jemec, Joslyn S. Kirby, Linnea Thorlacius, the HIdradenitis SuppuraTiva cORe outcomes set International Collaboration (HiSTORIC)   +20 more
wiley   +1 more source

Validation of the Shame Frequency Questionnaire in Turkish Medical Students. [PDF]

BMC Med Educ
Aktı Çakır E, Öztürk Emiral G, Sarıca Çevik H, Ungan M.   +3 more
europepmc   +1 more source

Psychodermatology of the Female: Hormones, Skin and Mental Health Across the Lifespan

JEADV Clinical Practice, EarlyView.
Hormonal transitions across the female lifespan shape skin disease and psychiatric comorbidity through the brain–skin axis and Neuro‐Immuno‐Cutaneous‐Endocrine (NICE) network. This narrative review links puberty, menstruation, pregnancy, postpartum and menopause to dermatologic and psychosocial outcomes.
Sheila Sharifi, Jessica Gulati, Veranca Shah, Keira Barr, Mohammad Jafferany   +4 more
wiley   +1 more source

Socioeconomic Deprivation and Vocal Handicap in Adults With Voice Disorders

The Laryngoscope, EarlyView.
This study examined the relationship between socioeconomic deprivation and quality of life as measured by the Voice Handicap Index (VHI) in adults with voice disorders. Patients living with socioeconomic deprivation experienced greater voice‐related handicap from voice disorders than those from more affluent backgrounds, even when controlling for ...
Robert Brinton Fujiki, Susan L. Thibeault   +1 more
wiley   +1 more source

Shame and trauma are critical to understanding the impacts of psychosis: Examining clinical correlates within a tertiary psychosis service cohort. [PDF]

Aust N Z J Psychiatry
Davies K, Lappin JM, Isobel S, Steel Z.
europepmc   +1 more source

The Dilemma of Carbon‐Conscious Consumers: A Multi‐Study Investigation of Carbon Transparency in AI Use

Psychology &Marketing, EarlyView.
ABSTRACT As artificial intelligence (AI) becomes embedded in everyday consumer services, it introduces ethical dilemmas that extend beyond fairness and privacy. One underexplored concern is the environmental cost of AI, particularly its carbon footprint.
Vik Naidoo
wiley   +1 more source

How Perceived Control and Task Value Relate to Achievement Emotions in Academic Study Settings. [PDF]

Behav Sci (Basel)
Raccanello D, Vicentini G, Putwain DW.
europepmc   +1 more source

Living with the Unknown: Intolerance of Uncertainty in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Parkinson's disease (PD) is marked by pervasive uncertainty due to fluctuating motor and non‐motor symptoms, variable treatment response, and an unpredictable clinical course. Intolerance of uncertainty (IU), a tendency to perceive ambiguity as threatening and respond with worry, avoidance, or decisional paralysis, may be ...
Bradley McDaniels, Gregory M. Pontone, Kuhan Pushparatnam, Indu Subramanian   +3 more
wiley   +1 more source

Willingness to use a mobile syringe service program among people who inject drugs in rural Appalachia. [PDF]

Harm Reduct J
Elswick A, Fallin-Bennett A, Jahangir T, Westneat S, Young AM.   +4 more
europepmc   +1 more source

The Uncharted Territory of the New Obesity Drugs in Users Without Obesity: A Sociomedical Perspective

Obesity, EarlyView.
ABSTRACT The off‐label use of glucagon‐like peptide‐1 receptor agonists (GLP‐1ra) among people without obesity and/or diabetes is rapidly expanding, despite a lack of clinical justification or safety data in this population. This Perspective explores the sociomedical dimensions of this trend, highlighting key research gaps and emerging hypotheses ...
Fernanda Baeza Scagliusi, Bruno Gualano, Pernille Andreassen, Cindi SturtzSreetharan, Sissel Due Jensen, Alexandra Brewis   +5 more
wiley   +1 more source